Home Tags ADCs

Tag: ADCs

ASCO 2019 ADC Presentation Guide

We have created the following guide to all presentations related to ADCs for the upcoming ASCO Annual Meeting 2019 taking place at the McCormick...

Emerging Trends in Single-Use Technology in the Manufacturing of Antibody-Drug...

Single-use technology, designed for the manufacturing of biopharmaceutical products, has made major inroads over the last 30 years. First introduced in the late 1970s...

California Life Sciences Association Rewards Sutro Biopharma with Outstanding Partner Award

This week, during the California Life Sciences Association (CLSA) annual Pantheon Ceremony (DiNA Awards), Sutro Biopharma received the Outstanding Partner Award. By giving this award to Sutro, the...

CPhI Worldwide 2015, Antibody-drug Conjugates and Market Progression

Ahead of CPhI Worldwide 2015, CPhI expert panelist, Vivek Sharma, CEO of Pharma Solutions at Piramal, analyses the challenges in developing and manufacturing of...

Event Preview: CPhI Worldwide 2015

CPhI Worldwide 2015 returns to Madrid, Spain, for the 26th edition, bringing with it the booming pharmaceutical industry ready for a plethora of networking,...

Downstream Processing Considerations for Antibody Variant Therapeutics

Abstract Novel platforms such as antibody derivatives, peptide based therapies, gene and stem cell based therapies are gaining foothold in the market for several reasons,...

Sorrento Therapeutics Completes Acquisition of Concortis Biosystems

Sorrento Therapeutics, Inc. announced today that it has completed its acquisition of Concortis Biosystems, Corp. The transaction provides Sorrento with a comprehensive antibody-drug conjugate...

Investigational Antibody-Drug Conjugate, Shows Encouraging Results in Women With Highly Advanced...

Results of a Phase II study of trastuzumab (Herceptin®, Genentech) in combination with DM1 (T-DM1), an investigational HER2 antibody-drug conjugate being developed by Genentech,...

DOWNLOAD